138 related articles for article (PubMed ID: 16011981)
1. No effect of taurine on platelet aggregation in men with a predisposition to type 2 diabetes mellitus.
Spohr C; Brøns C; Winther K; Dyerberg J; Vaag A
Platelets; 2005 Aug; 16(5):301-5. PubMed ID: 16011981
[TBL] [Abstract][Full Text] [Related]
2. Randomized comparison of a high clopidogrel maintenance dose in patients with diabetes mellitus and coronary artery disease: results of the Optimizing Antiplatelet Therapy in Diabetes Mellitus (OPTIMUS) study.
Angiolillo DJ; Shoemaker SB; Desai B; Yuan H; Charlton RK; Bernardo E; Zenni MM; Guzman LA; Bass TA; Costa MA
Circulation; 2007 Feb; 115(6):708-16. PubMed ID: 17261652
[TBL] [Abstract][Full Text] [Related]
3. Effects of arachidonate-enriched triacylglycerol supplementation on serum fatty acids and platelet aggregation in healthy male subjects with a fish diet.
Kusumoto A; Ishikura Y; Kawashima H; Kiso Y; Takai S; Miyazaki M
Br J Nutr; 2007 Sep; 98(3):626-35. PubMed ID: 17445350
[TBL] [Abstract][Full Text] [Related]
4. Effect of taurine treatment on insulin secretion and action, and on serum lipid levels in overweight men with a genetic predisposition for type II diabetes mellitus.
Brøns C; Spohr C; Storgaard H; Dyerberg J; Vaag A
Eur J Clin Nutr; 2004 Sep; 58(9):1239-47. PubMed ID: 15054439
[TBL] [Abstract][Full Text] [Related]
5. Impact of platelet reactivity on cardiovascular outcomes in patients with type 2 diabetes mellitus and coronary artery disease.
Angiolillo DJ; Bernardo E; Sabaté M; Jimenez-Quevedo P; Costa MA; Palazuelos J; Hernández-Antolin R; Moreno R; Escaned J; Alfonso F; Bañuelos C; Guzman LA; Bass TA; Macaya C; Fernandez-Ortiz A
J Am Coll Cardiol; 2007 Oct; 50(16):1541-7. PubMed ID: 17936152
[TBL] [Abstract][Full Text] [Related]
6. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
Serebruany VL; Malinin AI; Pokov AN; Hanley DF
Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
[TBL] [Abstract][Full Text] [Related]
7. Platelet inhibitory activity and pharmacokinetics of prasugrel (CS-747) a novel thienopyridine P2Y12 inhibitor: a single ascending dose study in healthy humans.
Asai F; Jakubowski JA; Naganuma H; Brandt JT; Matsushima N; Hirota T; Freestone S; Winters KJ
Platelets; 2006 Jun; 17(4):209-17. PubMed ID: 16769598
[TBL] [Abstract][Full Text] [Related]
8. [ADP-induced aggregation of human platelets in diabetes mellitus].
Chirkov IuIu; Tyshchiuk IA; Severina IS; Starosel'tseva LK
Vopr Med Khim; 1990; 36(4):20-2. PubMed ID: 2238525
[TBL] [Abstract][Full Text] [Related]
9. Effect of caffeine on platelet inhibition by clopidogrel in healthy subjects and patients with coronary artery disease.
Lev EI; Arikan ME; Vaduganathan M; Alviar CL; Tellez A; Mathuria N; Builes A; Granada JF; del Conde I; Kleiman NS
Am Heart J; 2007 Oct; 154(4):694.e1-7. PubMed ID: 17892993
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study.
Gurbel PA; Bliden KP; DiChiara J; Newcomer J; Weng W; Neerchal NK; Gesheff T; Chaganti SK; Etherington A; Tantry US
Circulation; 2007 Jun; 115(25):3156-64. PubMed ID: 17562955
[TBL] [Abstract][Full Text] [Related]
11. No effect of lipid lowering on platelet activity in patients with coronary artery disease and type 2 diabetes or impaired glucose tolerance.
Malmström RE; Settergren M; Böhm F; Pernow J; Hjemdahl P
Thromb Haemost; 2009 Jan; 101(1):157-64. PubMed ID: 19132203
[TBL] [Abstract][Full Text] [Related]
12. Meal-induced platelet activation in Type 2 diabetes mellitus: effects of treatment with repaglinide and glibenclamide.
Yngen M; Ostenson CG; Hjemdahl P; Wallén NH
Diabet Med; 2006 Feb; 23(2):134-40. PubMed ID: 16433710
[TBL] [Abstract][Full Text] [Related]
13. Effect of fast-food Mediterranean-type diet on type 2 diabetics and healthy human subjects' platelet aggregation.
Karantonis HC; Fragopoulou E; Antonopoulou S; Rementzis J; Phenekos C; Demopoulos CA
Diabetes Res Clin Pract; 2006 Apr; 72(1):33-41. PubMed ID: 16236380
[TBL] [Abstract][Full Text] [Related]
14. Comparison of increased aspirin dose versus combined aspirin plus clopidogrel therapy in patients with diabetes mellitus and coronary heart disease and impaired antiplatelet response to low-dose aspirin.
Duzenli MA; Ozdemir K; Aygul N; Soylu A; Tokac M
Am J Cardiol; 2008 Aug; 102(4):396-400. PubMed ID: 18678294
[TBL] [Abstract][Full Text] [Related]
15. Platelet aggregation in obese and diabetic subjects: association with leptin level.
Sugiyama C; Ishizawa M; Kajita K; Morita H; Uno Y; Matsubara K; Matsumoto M; Ikeda T; Ishizuka T
Platelets; 2007 Mar; 18(2):128-34. PubMed ID: 17365861
[TBL] [Abstract][Full Text] [Related]
16. Effects of garlic oil on platelet aggregation: a double-blind placebo-controlled crossover study.
Wojcikowski K; Myers S; Brooks L
Platelets; 2007 Feb; 18(1):29-34. PubMed ID: 17365851
[TBL] [Abstract][Full Text] [Related]
17. A pilot study to examine the feasibility of insulin glargine in subjects with impaired fasting glucose, impaired glucose tolerance or new-onset type 2 diabetes.
Marbury TC; Schwartz S; Rosenberg MA; Jariwala N; Becker RH; Johnston PS
Exp Clin Endocrinol Diabetes; 2008 May; 116(5):282-8. PubMed ID: 18484560
[TBL] [Abstract][Full Text] [Related]
18. Trapidil decreases the aggregation of platelets from heart transplant recipients ex vivo.
Jovin IS; Taborski U; Szalay Z; Friedel A; Segieth I; Jovin A; Heidinger K; Schreiner K; Frass O; Klövekorn WP; Müller-Berghaus G
Transplant Proc; 2006 Jun; 38(5):1523-5. PubMed ID: 16797349
[TBL] [Abstract][Full Text] [Related]
19. A global platelet test of thrombosis and thrombolysis detects a prothrombotic state in some patients with non-insulin dependent diabetes and in some patients with stroke.
Nakajima S; Noguchi T; Taka T; Ueda T; Kaizu K; Fukamizu M; Fujita S; Tabuchi M; Yamamoto J
Platelets; 2000 Dec; 11(8):459-66. PubMed ID: 11177445
[TBL] [Abstract][Full Text] [Related]
20. Platelet inhibitory activity and pharmacokinetics of prasugrel (CS-747) a novel thienopyridine P2Y12 inhibitor: a multiple-dose study in healthy humans.
Matsushima N; Jakubowski JA; Asai F; Naganuma H; Brandt JT; Hirota T; Freestone S; Winters KJ
Platelets; 2006 Jun; 17(4):218-26. PubMed ID: 16769599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
